oncodaily - Young Kwang Chae, Professor and Co-Director of Developmental Therapeutics, Lurie Cancer Center at Northwestern University, shared a post on X: “I am happy to share our first comprehensive report of […]
AI Summary: The DREAM study reports an eye‑popping 100% one‑year survival among a very select group of lung transplant recipients, including patients with advanced lung cancer. Enthusiasm is tempered by small cohort size and selection bias concerns, but the results hint that transplantation could be a viable life‑extending option for carefully chosen patients.
High‑dose targeted radiation shows promise for huge bile duct tumors / 3 months
Two high‑dose radiotherapy sessions safely treat localized prostate cancer / 7 wks
ESMO issues new metastatic colorectal cancer clinical guideline / 2 months
SBRT extends progression‑free survival in oligometastatic breast cancer / 7 wks
Ovarian suppression with tamoxifen cuts recurrence in premenopausal breast cancer / 4 days
Journal retracts study claiming morning immunotherapy benefit / 13 days
Perioperative apalutamide plus ADT improves high‑risk prostate outcomes / 5 wks
StackHealth RSS


StackHealth Time Machine
NorthFeed Inc. Terms and Conditions / Privacy Policy
Disclaimer: The information provided on this website is intended for general informational purposes only. While we strive for accuracy, we do not guarantee the completeness or reliability of the content. Users are encouraged to verify all details independently. We accept no liability for errors, omissions, or any decisions made based on this information.